Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
26 mai 2021 09h15 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, May 26, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...